Active Hexose Correlated Compound (AHCC) Alleviates Gemcitabine-Induced Hematological Toxicity in Non-Tumor-Bearing Mice

Journals Menu

Follow SCIRP

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.org/journal/ijcm
E-mail: ijcm@scirp.org

"Active Hexose Correlated Compound (AHCC) Alleviates Gemcitabine-Induced Hematological Toxicity in Non-Tumor-Bearing Mice"
written by Daisuke Nakamoto, Kota Shigama, Hiroshi Nishioka, Hajime Fujii,
published by International Journal of Clinical Medicine, Vol.3 No.5, 2012

has been cited by the following article(s):

[1]	The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving …
	2017

[2]	The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer …
	Asian Pacific journal of cancer prevention: APJCP, 2017

[3]	Alleviating effect of active hexose correlated compound (AHCC) on chemotherapy-related adverse events in patients with unresectable pancreatic ductal adenocarcinoma
	Nutrition and cancer, 2016

[4]	Alleviating effect of active hexose correlated compound (AHCC) on chemotherapy-related adverse events in patients with unresectable pancreatic ductal …
	Nutrition and Cancer, 2016

[5]	Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells
	Anticancer research, 2015

[6]	Active Hexose-correlated Compound Down-regulates HSP27 of Pancreatic Cancer Cells, and Helps the Cytotoxic Effect of Gemcitabine
	Anticancer research, 2014

Follow SCIRP